We welcome Erik Walldén as a new member of in the board of directors. Mr. Erik Walldén has a record of achievement from over 30 years leadership in the international Life Science industry. He has led the global launching of several new technologies, established and restructured companies, successfully closed private placements and IPOs.

He is currently acting as private investor, consultant and advisor through his own company Erik Wallden AB. Mr. Wallden has been the CEO for the Swedish company Gyros AB (2009-2013. Before that the CEO of the Swedish biotech company Affibody Holding AB (2006-2009), Biacore International AB (2004-2006), and before that the CEO of Pyrosequencing AB (1998-2004).

He has been active in establishing and part of the executive management of companies such as the US based PerSeptive Biosystems Inc., Pharmacia Biosensor AB and Pharmacia Biotech AB. Mr. Walldén is the Chairman of the Board of Erik Wallden AB and member of the boards of Beactica AB and Symcel AB.